The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs
Today, a combination of globalization of pharmaceutical production, lack of regulatory harmonization, and weakness of Medicines Regulatory Authorities, creates the “perfect conditions” for poor-quality medicine to circulate in the global market and to penetrate the less-regulated countries. Medicines regulation is the responsibility of the national regulatory authorities in the recipient country, but in the poorer countries, in practice, the responsibility of supply of quality-assured medicines is often taken by Non-Governmental Organizations and other implementers. But with some notable excep... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Reihe/Periodikum: | Journal of Pharmaceutical Policy and Practice, Vol 11, Iss 1 (2018) |
Verlag/Hrsg.: |
Taylor & Francis Group
|
Schlagwörter: | quality of medicines / quality assurance / belgium / low-income countries / capacity-building / pharmaceutical policy / supply / Therapeutics. Pharmacology / RM1-950 / Pharmacy and materia medica / RS1-441 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28531550 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1186/s40545-018-0136-z |